Mark Lappe, Director, 10% Owner at REPROS THERAPEUTICS INC. (RPRX), bought 34,292 shares at $6.87 ($238K) on 2008-10-28, disclosed to the SEC on 2008-10-30.
Open-market purchase of $238k RPRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.87 | 9,892 | $68K | 28.6% |
| 2 | $6.97 | 24,400 | $170K | 71.4% |
| Total | $6.94 avg | 34,292 | $238K | 100% |
| Filing → |
| INBX | BUY | 2024-09-10 | $671K | — | Filing → |
| INBX | BUY | 2024-09-03 | $913K | — | Filing → |
| INBX | BUY | 2024-08-22 | $1.0M | — | Filing → |